Cargando…
New Agents for Targeting of IL-13RA2 Expressed in Primary Human and Canine Brain Tumors
Interleukin 13 receptor alpha 2 (IL-13RA2) is over-expressed in a vast majority of human patients with high-grade astrocytomas like glioblastoma. Spontaneous astrocytomas in dogs resemble human disease and have been proposed as translational model system for investigation of novel therapeutic strate...
Autores principales: | Debinski, Waldemar, Dickinson, Peter, Rossmeisl, John H., Robertson, John, Gibo, Denise M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797726/ https://www.ncbi.nlm.nih.gov/pubmed/24147065 http://dx.doi.org/10.1371/journal.pone.0077719 |
Ejemplares similares
-
Phase I trial of convection-enhanced delivery of IL13RA2 and EPHA2 receptor targeted cytotoxins in dogs with spontaneous intracranial gliomas
por: Rossmeisl, John H, et al.
Publicado: (2020) -
Expression and activity of the urokinase plasminogen activator system in canine primary brain tumors
por: Rossmeisl, John H, et al.
Publicado: (2017) -
Frame-Based Stereotactic Biopsy of Canine Brain Masses: Technique and Clinical Results in 26 Cases
por: Rossmeisl, John Henry, et al.
Publicado: (2015) -
Peptide-based PET imaging of the tumor restricted IL13RA2 biomarker
por: Sai, Kiran Kumar Solingapuram, et al.
Publicado: (2017) -
IL13RA2 targeted alpha particle therapy against glioblastomas
por: Sattiraju, Anirudh, et al.
Publicado: (2017)